Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
15.45
-0.22 (-1.40%)
Oct 22, 2026, 3:40 PM HKT

Sinopharm Group Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
571,924575,168584,508596,570552,148521,051
Revenue Growth
-0.68%-1.60%-2.02%8.04%5.97%14.16%
Gross Profit
40,39741,67244,25548,51247,43444,051
Operating Income
16,85517,23017,81922,31822,76420,984
Net Income
7,0937,1557,0509,0548,5267,759
Earnings Per Share
2.272.292.262.902.742.49
EPS Growth
4.00%1.37%-22.10%6.02%10.02%7.63%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Eliminations
-24,696-22,997-22,860-20,769-18,496-15,913
Medical Device Distribution
115,339115,538117,915130,213120,851108,129
Other Business
9,0658,8539,10610,38610,2099,821
Retail Pharmacy
39,85638,38335,98135,68932,97929,059
Pharmaceutical Distribution
432,360435,392444,365441,051406,604389,955
Total
571,924575,168584,508596,570552,148521,051

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
31,04551,55457,48667,13958,42146,353
Total Debt
81,31670,96076,38673,78269,59068,368
Net Cash (Debt)
-50,271-19,407-18,900-6,643-11,169-22,016
Net Cash Growth
------
Net Cash Per Share
-16.11-6.22-6.06-2.13-3.58-7.05

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
24,48714,13811,54617,17320,9649,308
Capital Expenditures
-1,455-1,496-1,471-1,960-2,127-2,074
Free Cash Flow
23,03112,64210,07515,21318,8377,234
Free Cash Flow Growth
32.72%25.49%-33.78%-19.23%160.38%-21.85%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
7.06%7.25%7.57%8.13%8.59%8.45%
Operating Margin
2.95%3.00%3.05%3.74%4.12%4.03%
Pretax Margin
2.54%2.57%2.40%3.27%3.36%3.26%
Profit Margin
1.24%1.24%1.21%1.52%1.54%1.49%
FCF Margin
4.03%2.20%1.72%2.55%3.41%1.39%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.8050.6900.6800.8700.8200.750
Dividend Per Share Growth
6.90%1.47%-21.84%6.10%9.33%8.70%
Dividend Yield
5.21%3.95%3.40%4.69%4.67%5.43%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
5.907.628.866.406.425.56
Forward PE
5.426.857.015.826.054.93
P/FCF Ratio
1.844.316.203.812.915.96
PS Ratio
0.070.100.110.100.100.08